Fate Therapeutics (FATE) EBITDA Margin (QoQ) (2012 - 2026)
Fate Therapeutics (FATE) EBITDA Margin (QoQ) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Fate Therapeutics |
250.86 Mn |
250.86 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-5,021.00 |
| Dec 31, 2025 |
-52,034.00 |
| Sep 30, 2025 |
-5,382.00 |
| Jun 30, 2025 |
52,084.00 |
| Mar 31, 2025 |
52,023.00 |
| Dec 31, 2024 |
-132,429.00 |
| Sep 30, 2024 |
-93,931.00 |
| Jun 30, 2024 |
193,377.00 |
| Mar 31, 2024 |
9,734.00 |
| Dec 31, 2023 |
-28,288.00 |
| Sep 30, 2023 |
332,898.00 |
| Jun 30, 2023 |
-561,805.00 |
| Mar 31, 2023 |
9,395.00 |
| Dec 31, 2022 |
43,302.00 |
| Sep 30, 2022 |
-14,378.00 |
| Jun 30, 2022 |
-4,508.00 |
| Mar 31, 2022 |
3,798.00 |
| Dec 31, 2021 |
-10,170.00 |
| Sep 30, 2021 |
10,542.00 |
| Jun 30, 2021 |
-214.00 |
